Summary
- Current Price
- As of today, DSGN price is $13.99, up +1.60% on
- Current Price All-Time High
- DSGN price is currently -67.47% below its historical high of $43.00 set on
- Market Cap
- DSGN current market cap is $876M, up +287.25% over the past 365 days
- Revenue
- DSGN current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for DSGN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Design Therapeutics, Inc. |
| Ticker | NASDAQ: DSGN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | designtx.com |
| Employees | 56 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $13.99 | |
| Price, 1D Change | +1.60% | |
| $876M | ||
| - | ||
| - | ||
| 1.27 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.22 | ||
| EPS, 1Y Change | -38.93% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.22 | ||
| EPS Estimate | -$1.41 | N/A |
| EPS Est. Change | -15.66% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $13.99 | |
| Price Target | $21.00 | - |
| Price Tgt. Change | +50.11% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.90 | -$0.88 | +2.63% | |
| -$1.30 | -$1.22 | +6.50% | |
| -$1.41 | N/A | -15.66% | |
| -$1.61 | N/A | -32.60% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $13.99 | |
| $10.80 | ||
| $12.58 | ||
| $10.83 | ||
| $12.79 | ||
| $0.10 | ||
| 1.27 | ||
| $0.83 | ||
| 61.53 | ||
| 39.42% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$1.22 | ||
| -$622.00K | ||
| - | ||
| -$79.47M | ||
| - | ||
| -$69.79M | ||
| - | ||
| -$78.85M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.01 | ||
| 17.14 | ||
| 17.14 | ||
| - | ||
| - | ||
| 35.00 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 4.34 | ||
| -8.52 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $212.50M | ||
| $219.85M | ||
| $226.75M | ||
| $223.78M | ||
| $14.25M | ||
| $13.06M | ||
| $1.54M | ||
| $890.00K | ||
| $2.31M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $69.79M | ||
| $78.85M | ||
| $622.00K | ||
| $0.00 | ||
| $622.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$54.36M | ||
| $22.91M | ||
| $25.74M | ||
| $193.00K | ||
| -$54.55M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Oppenheimer | → | |
| Jefferies | ||
| RBC Capital | → | |
| Oppenheimer | ||
| Leerink Partners | → | |
| RBC Capital | → | |
| RBC Capital | → | |
| RBC Capital | → | |
| Piper Sandler | → | |
| Wedbush | → |
Analyst sentiment
Institutional ownership
Screeners with DSGN
FAQ
- What is the ticker symbol for Design Therapeutics, Inc.?
- The ticker symbol for Design Therapeutics, Inc. is NASDAQ:DSGN
- Does Design Therapeutics, Inc. pay dividends?
- No, Design Therapeutics, Inc. does not pay dividends
- What sector is Design Therapeutics, Inc. in?
- Design Therapeutics, Inc. is in the Healthcare sector
- What industry is Design Therapeutics, Inc. in?
- Design Therapeutics, Inc. is in the Biotechnology industry
- What country is Design Therapeutics, Inc. based in?
- Design Therapeutics, Inc. is headquartered in United States
- When did Design Therapeutics, Inc. go public?
- Design Therapeutics, Inc. initial public offering (IPO) was on March 29, 2021
- Is Design Therapeutics, Inc. in the S&P 500?
- No, Design Therapeutics, Inc. is not included in the S&P 500 index
- Is Design Therapeutics, Inc. in the NASDAQ 100?
- No, Design Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Design Therapeutics, Inc. in the Dow Jones?
- No, Design Therapeutics, Inc. is not included in the Dow Jones index
- When was Design Therapeutics, Inc. last earnings report?
- Design Therapeutics, Inc.'s most recent earnings report was on August 3, 2026
- When does Design Therapeutics, Inc. report earnings?
- The next expected earnings date for Design Therapeutics, Inc. is November 5, 2026
Data Sources & References
- DSGN Official Website www.designtx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1807120/000119312526098491/0001193125-26-098491-index.htm
- DSGN Profile on Yahoo Finance finance.yahoo.com/quote/DSGN
- DSGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dsgn